| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049569725 |
| P356 | DOI | 10.1007/S00436-013-3383-6 |
| P698 | PubMed publication ID | 23529336 |
| P5875 | ResearchGate publication ID | 236081048 |
| P2093 | author name string | Shailja Misra-Bhattacharya | |
| Ajay Kumar Rana | |||
| P2860 | cites work | Synthesis of 4-amino-5-cyano-2, 6-disubstituted pyrimidines as a potential antifilarial DNA topoisomerase II inhibitors | Q46258668 |
| Research progress on the action of praziquantel on voltage-gated Ca2+ channel in schistosomes | Q46475942 | ||
| The SLO-1 BK channel of Caenorhabditis elegans is critical for muscle function and is involved in dystrophin-dependent muscle dystrophy | Q46983106 | ||
| Identification and characterization of myophilin-like protein: a life stage and tissue-specific antigen of Clonorchis sinensis | Q47427658 | ||
| Functional analysis of novel aquaporins from Fasciola gigantica | Q48061766 | ||
| Cloning and characterization of genes encoding alpha and beta subunits of glutamate-gated chloride channel protein in Cylicocyclus nassatus | Q48085782 | ||
| Finding function in novel targets: C. elegans as a model organism | Q49168922 | ||
| Evolution of complex life cycles in helminth parasites. | Q52008508 | ||
| Exploiting structural biology in the fight against parasitic diseases. | Q53661804 | ||
| Mapping the pro-peptide of the Schistosoma mansoni cathepsin B1 drug target: modulation of inhibition by heparin and design of mimetic inhibitors. | Q54607580 | ||
| Drug transfer into target helminth parasites | Q79607835 | ||
| The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in Caenorhabditis elegans | Q80510590 | ||
| The physiology of helminth parasites in relation to disease | Q82390881 | ||
| Axenic in vitro cultivation of Echinococcus multilocularis metacestode vesicles and the generation of primary cell cultures | Q83001184 | ||
| Gedunin and photogedunin of Xylocarpus granatum possess antifilarial activity against human lymphatic filarial parasite Brugia malayi in experimental rodent host | Q83978559 | ||
| Cloning, expression, purification and kinetics of trehalose-6-phosphate phosphatase of filarial parasite Brugia malayi | Q84318082 | ||
| [Progress in the development of vaccines against helminths] | Q84385006 | ||
| Wnt4, the first member of the Wnt family identified in Schistosoma japonicum, regulates worm development by the canonical pathway | Q84469070 | ||
| RNAi-mediated silencing of a novel Ascaris suum gene expression in infective larvae | Q84757532 | ||
| A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity | Q21092297 | ||
| Identification of attractive drug targets in neglected-disease pathogens using an in silico approach | Q21144522 | ||
| Of mice, cattle, and humans: the immunology and treatment of river blindness | Q21144551 | ||
| A research agenda for helminth diseases of humans: Intervention for control and elimination | Q21562256 | ||
| The Wolbachia genome of Brugia malayi: endosymbiont evolution within a human pathogenic nematode | Q21563623 | ||
| Helminth infections: the great neglected tropical diseases | Q24648324 | ||
| Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects | Q24652462 | ||
| Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria | Q25256957 | ||
| Helminth parasite proteomics: from experimental models to human infections | Q26863301 | ||
| The new anthelmintic tribendimidine is an L-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist | Q27306806 | ||
| SLO-1-channels of parasitic nematodes reconstitute locomotor behaviour and emodepside sensitivity in Caenorhabditis elegans slo-1 loss of function mutants | Q27312012 | ||
| Targeting protein-protein interactions for parasite control | Q27348831 | ||
| Identification of the nuclear receptor DAF-12 as a therapeutic target in parasitic nematodes | Q27655744 | ||
| Discovery and molecular characterization of a Bcl-2-regulated cell death pathway in schistosomes | Q27667342 | ||
| Structural and functional characterization ofSchistosoma mansoniThioredoxin | Q27667437 | ||
| Principles of activation and permeation in an anion-selective Cys-loop receptor | Q27667848 | ||
| Structural Basis for Inhibition of Cathepsin B Drug Target from the Human Blood Fluke, Schistosoma mansoni | Q27671668 | ||
| An anthelmintic compound, nafuredin, shows selective inhibition of complex I in helminth mitochondria | Q28345186 | ||
| Mining predicted essential genes of Brugia malayi for nematode drug targets | Q28471588 | ||
| Haemonchus contortus acetylcholine receptors of the DEG-3 subfamily and their role in sensitivity to monepantel | Q28475244 | ||
| The heme biosynthetic pathway of the obligate Wolbachia endosymbiont of Brugia malayi as a potential anti-filarial drug target | Q28475720 | ||
| The nicotinic acetylcholine receptors of the parasitic nematode Ascaris suum: formation of two distinct drug targets by varying the relative expression levels of two subunits | Q28475744 | ||
| Development of an in vivo RNAi protocol to investigate gene function in the filarial nematode, Brugia malayi | Q28476628 | ||
| Targeting the Wolbachia cell division protein FtsZ as a new approach for antifilarial therapy | Q28478176 | ||
| HelmCoP: an online resource for helminth functional genomics and drug and vaccine targets prioritization | Q28478955 | ||
| In vitro silencing of Brugia malayi trehalose-6-phosphate phosphatase impairs embryogenesis and in vivo development of infective larvae in jirds | Q28482248 | ||
| Nematode.net update 2011: addition of data sets and tools featuring next-generation sequencing data | Q28740950 | ||
| Two allelic isoforms of the serotonin transporter from Schistosoma mansoni display electrogenic transport and high selectivity for serotonin | Q28751482 | ||
| An updated atlas of human helminth infections: the example of East Africa | Q28752190 | ||
| Control of neglected tropical diseases | Q29547285 | ||
| Soil-transmitted helminth infections: updating the global picture | Q29619026 | ||
| A research agenda for helminth diseases of humans: Health research and capacity building in disease-endemic countries for helminthiases control | Q30395360 | ||
| Selective toxicity of the anthelmintic emodepside revealed by heterologous expression of human KCNMA1 in Caenorhabditis elegans | Q30500560 | ||
| Microscopy and the helminth parasite | Q33199021 | ||
| Molecular cloning and characterization of a novel lactate dehydrogenase gene from Clonorchis sinensis | Q33233945 | ||
| Expression and characterization of lactate dehydrogenase from Schistosoma japonicum | Q33243087 | ||
| Molecular cloning and characterization of a novel immunoreactive ATPase/RNA helicase in human filarial parasite Brugia malayi | Q33383895 | ||
| The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling. | Q33505762 | ||
| Schistosomes of small mammals from the Lake Victoria Basin, Kenya: new species, familiar species, and implications for schistosomiasis control. | Q33551633 | ||
| Thioredoxin and glutathione systems differ in parasitic and free-living platyhelminths | Q33552863 | ||
| Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility | Q33778375 | ||
| Eukaryotic protein kinases (ePKs) of the helminth parasite Schistosoma mansoni | Q33891612 | ||
| The drugs we have and the drugs we need against major helminth infections | Q34125793 | ||
| Producing parasitic helminth reference and draft genomes at the Wellcome Trust Sanger Institute. | Q34195606 | ||
| Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes | Q34243810 | ||
| The N terminus of a schistosome beta subunit regulates inactivation and current density of a Cav2 channel | Q34285344 | ||
| Vasa-Like DEAD-Box RNA Helicases of Schistosoma mansoni | Q34312417 | ||
| SmSak, the second Polo-like kinase of the helminth parasite Schistosoma mansoni: conserved and unexpected roles in meiosis | Q34328607 | ||
| Linked thioredoxin-glutathione systems in platyhelminth parasites: alternative pathways for glutathione reduction and deglutathionylation. | Q34568264 | ||
| Anthelmintic resistance: markers for resistance, or susceptibility? | Q34721432 | ||
| A new class of anthelmintics effective against drug-resistant nematodes | Q34761361 | ||
| Tirandamycins from Streptomyces sp. 17944 inhibiting the parasite Brugia malayi asparagine tRNA synthetase | Q34778863 | ||
| The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery | Q35137624 | ||
| Molecular characterization of cathepsin B from Clonorchis sinensis excretory/secretory products and assessment of its potential for serodiagnosis of clonorchiasis | Q35185009 | ||
| Parasite mitochondria as drug target: diversity and dynamic changes during the life cycle | Q35552088 | ||
| Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production | Q35664315 | ||
| The nematode neuropeptide, AF2 (KHEYLRF-NH2), increases voltage-activated calcium currents in Ascaris suum muscle. | Q36053129 | ||
| Multidrug resistance in parasites: ABC transporters, P-glycoproteins and molecular modelling | Q36096408 | ||
| Development of an in vitro drug screening assay using Schistosoma haematobium schistosomula | Q36219372 | ||
| Schistosomiasis--a century searching for chemotherapeutic drugs. | Q36459174 | ||
| Helminths: Immunoregulation and Inflammatory Diseases-Which Side Are Trichinella spp. and Toxocara spp. on? | Q36567307 | ||
| Ion-channels on parasite muscle: pharmacology and physiology | Q36999732 | ||
| An ivermectin-sensitive glutamate-gated chloride channel from the parasitic nematode Haemonchus contortus | Q37199078 | ||
| Helminth infections and intestinal inflammation | Q37262993 | ||
| Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis | Q37315241 | ||
| Discovery of multiple neuropeptide families in the phylum Platyhelminthes. | Q37358296 | ||
| Ion channels and receptor as targets for the control of parasitic nematodes | Q37501925 | ||
| Drug resistance mechanisms in helminths: is it survival of the fittest? | Q37525674 | ||
| Our wormy world genomics, proteomics and transcriptomics in East and southeast Asia. | Q37772267 | ||
| Neuropeptides in helminths: occurrence and distribution. | Q37824386 | ||
| Neuropeptide physiology in helminths. | Q37824387 | ||
| Functional genomics approaches in parasitic helminths. | Q37895332 | ||
| Mitochondrial fumarate reductase as a target of chemotherapy: from parasites to cancer cells | Q37973945 | ||
| Anthelmintic metabolism in parasitic helminths: proteomic insights | Q38024902 | ||
| Heterologous antagonistic and synergistic interactions between helminths and between helminths and protozoans in concurrent experimental infection of mammalian hosts | Q39671143 | ||
| Molecular characterizations of an inhibitor of apoptosis from Schistosoma japonicum | Q39738417 | ||
| Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors | Q39940315 | ||
| Effects of gastrointestinal nematode infection on the ruminant immune system | Q41699411 | ||
| Identification, expression, characterization, and immunolocalization of lactate dehydrogenase from Taenia asiatica | Q42599430 | ||
| Liver fluke β-tubulin isotype 2 binds albendazole and is thus a probable target of this drug | Q42949830 | ||
| Apigenin inhibits larval growth of Caenorhabditis elegans through DAF-16 activation | Q42963853 | ||
| 4-Methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one: a novel DNA topoisomerase II inhibitor with adulticidal and embryostatic activity against sub-periodic Brugia malayi | Q42981704 | ||
| Molecular cloning and characterization of a gene encoding methionine aminopeptidase 2 of Schistosoma japonicum | Q43003918 | ||
| In vitro killing action of auranofin on Taenia crassiceps metacestode (cysticerci) and inactivation of thioredoxin-glutathione reductase (TGR). | Q43078941 | ||
| Schistosoma mansoni Polo-like kinase 1: A mitotic kinase with key functions in parasite reproduction. | Q43115730 | ||
| Structural modeling and simulation studies of Brugia malayi glutathione-S-transferase with compounds exhibiting antifilarial activity: implications in drug targeting and designing | Q43229079 | ||
| Improvement in the antifilarial efficacy of doxycycline and rifampicin by combination therapy and drug delivery approach. | Q43232049 | ||
| RNA interference in a cestode reveals specific silencing of selected highly expressed gene transcripts. | Q43245542 | ||
| An interactive map to assess the potential spread of Lymnaea truncatula and the free-living stages of Fasciola hepatica in Switzerland | Q43458446 | ||
| The putative cyclooctadepsipeptide receptor depsiphilin of the canine hookworm Ancylostoma caninum | Q43888887 | ||
| Design, synthesis, anti-schistosomal activity and molecular docking of novel 8-hydroxyquinoline-5-sufonyl 1,4-diazepine derivatives. | Q44306970 | ||
| Molecular cloning and characterization of Schistosoma japonicum aldose reductase | Q44349734 | ||
| The cys-loop ligand-gated ion channel gene family of Brugia malayi and Trichinella spiralis: a comparison with Caenorhabditis elegans. | Q44891172 | ||
| The Wolbachia endosymbiont of Brugia malayi has an active phosphoglycerate mutase: a candidate target for anti-filarial therapies | Q45885346 | ||
| In vitro antifilarial activity of glutathione S-transferase inhibitors. | Q45948634 | ||
| Characterization and expression of the Schistosoma japonicum thioredoxin peroxidase-2 gene. | Q46001039 | ||
| Antifilarial activity of 1,3-diarylpropen-1-one: effect on glutathione-S-transferase, a phase II detoxification enzyme. | Q46029754 | ||
| FMRFamide-like neuropeptides as putative ligands of the latrophilin-like HC110-R from Haemonchus contortus | Q46173496 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 1819-1831 | |
| P577 | publication date | 2013-03-26 | |
| P1433 | published in | Parasitology Research | Q15755242 |
| P1476 | title | Current drug targets for helminthic diseases | |
| P478 | volume | 112 |
| Q33748419 | Activity of tea tree (Melaleuca alternifolia) essential oil against L3 larvae of Anisakis simplex |
| Q91658917 | Comparative Transcriptomic Analysis of the Larval and Adult Stages of Taenia pisiformis |
| Q36026159 | Functionalized Benzimidazole Scaffolds: Privileged Heterocycle for Drug Design in Therapeutic Medicine. |
| Q38309107 | Genome mining offers a new starting point for parasitology research |
| Q93000539 | Identification of small molecule enzyme inhibitors as broad-spectrum anthelmintics |
| Q45054942 | In vitro and in vivo screening of anthelmintic activity of ginger and curcumin on Ascaridia galli |
| Q42256292 | Molecular characterization and evaluation of Onchocerca volvulus-secreted larval acidic protein 1 (SLAP1) as a putative vaccine candidate on endemic population of lymphatic filariasis |
| Q37036576 | Molecular characterization of an rsmD-like rRNA methyltransferase from the Wolbachia endosymbiont of Brugia malayi and antifilarial activity of specific inhibitors of the enzyme |
| Q46760732 | Molecular characterization of voltage-gated calcium channel β-subunits of Clonorchis sinensis |
| Q34351234 | PGP expression in Cooperia oncophora before and after ivermectin selection |
| Q38964448 | Partial reverse of the TCA cycle is enhanced in Taenia crassiceps experimental neurocysticercosis after in vivo treatment with anthelminthic drugs |
| Q39003333 | Target-based molecular modeling strategies for schistosomiasis drug discovery. |
Search more.